nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—CYP3A7—Propranolol—migraine	0.0711	0.0948	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Propranolol—migraine	0.0711	0.0948	CbGbCtD
Temsirolimus—CYP3A5—Propranolol—migraine	0.0533	0.0711	CbGbCtD
Temsirolimus—CYP3A7—Verapamil—migraine	0.0488	0.0651	CbGbCtD
Temsirolimus—CYP3A7-CYP3A51P—Verapamil—migraine	0.0488	0.0651	CbGbCtD
Temsirolimus—CYP3A5—Amitriptyline—migraine	0.0461	0.0615	CbGbCtD
Temsirolimus—CYP3A5—Valproic Acid—migraine	0.042	0.0561	CbGbCtD
Temsirolimus—ABCB1—Timolol—migraine	0.0389	0.0519	CbGbCtD
Temsirolimus—CYP2D6—Timolol—migraine	0.0367	0.0489	CbGbCtD
Temsirolimus—CYP3A5—Verapamil—migraine	0.0366	0.0488	CbGbCtD
Temsirolimus—ABCB1—Propranolol—migraine	0.0347	0.0463	CbGbCtD
Temsirolimus—CYP2D6—Propranolol—migraine	0.0327	0.0436	CbGbCtD
Temsirolimus—ABCB1—Amitriptyline—migraine	0.03	0.04	CbGbCtD
Temsirolimus—CYP2D6—Amitriptyline—migraine	0.0283	0.0377	CbGbCtD
Temsirolimus—ABCB1—Verapamil—migraine	0.0238	0.0318	CbGbCtD
Temsirolimus—CYP2D6—Verapamil—migraine	0.0224	0.0299	CbGbCtD
Temsirolimus—CYP3A4—Propranolol—migraine	0.0208	0.0277	CbGbCtD
Temsirolimus—CYP3A4—Amitriptyline—migraine	0.018	0.024	CbGbCtD
Temsirolimus—CYP3A4—Valproic Acid—migraine	0.0164	0.0219	CbGbCtD
Temsirolimus—CYP3A4—Topiramate—migraine	0.0148	0.0197	CbGbCtD
Temsirolimus—CYP3A4—Verapamil—migraine	0.0143	0.019	CbGbCtD
Temsirolimus—MTOR—blood vessel—migraine	0.0015	0.12	CbGeAlD
Temsirolimus—MTOR—EGFR-dependent Endothelin signaling events—EDNRA—migraine	0.00125	0.0829	CbGpPWpGaD
Temsirolimus—MTOR—Type II diabetes mellitus—CACNA1A—migraine	0.00116	0.0772	CbGpPWpGaD
Temsirolimus—FKBP1A—TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)—TGFBR2—migraine	0.00109	0.0721	CbGpPWpGaD
Temsirolimus—FKBP1A—Role of Calcineurin-dependent NFAT signaling in lymphocytes—MEF2D—migraine	0.00109	0.072	CbGpPWpGaD
Temsirolimus—MTOR—neck—migraine	0.00107	0.0862	CbGeAlD
Temsirolimus—FKBP1A—neck—migraine	0.000963	0.0775	CbGeAlD
Temsirolimus—FKBP1A—trigeminal ganglion—migraine	0.000831	0.0669	CbGeAlD
Temsirolimus—MTOR—brainstem—migraine	0.000818	0.0658	CbGeAlD
Temsirolimus—FKBP1A—ALK1 signaling events—TGFBR2—migraine	0.000738	0.0489	CbGpPWpGaD
Temsirolimus—MTOR—cardiovascular system—migraine	0.000667	0.0537	CbGeAlD
Temsirolimus—FKBP1A—TGF-beta receptor signaling activates SMADs—TGFBR2—migraine	0.000625	0.0414	CbGpPWpGaD
Temsirolimus—FKBP1A—cardiovascular system—migraine	0.0006	0.0483	CbGeAlD
Temsirolimus—MTOR—IL4-mediated signaling events—LTA—migraine	0.000547	0.0363	CbGpPWpGaD
Temsirolimus—MTOR—head—migraine	0.000452	0.0364	CbGeAlD
Temsirolimus—FKBP1A—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.000448	0.0297	CbGpPWpGaD
Temsirolimus—FKBP1A—Calcium signaling in the CD4+ TCR pathway—FOS—migraine	0.00044	0.0292	CbGpPWpGaD
Temsirolimus—MTOR—nervous system—migraine	0.000429	0.0345	CbGeAlD
Temsirolimus—FKBP1A—TGF-beta receptor signaling—TGFBR2—migraine	0.000424	0.0281	CbGpPWpGaD
Temsirolimus—MTOR—central nervous system—migraine	0.000413	0.0332	CbGeAlD
Temsirolimus—FKBP1A—TGF-beta Receptor Signaling—TGFBR2—migraine	0.000411	0.0273	CbGpPWpGaD
Temsirolimus—FKBP1A—head—migraine	0.000407	0.0327	CbGeAlD
Temsirolimus—MTOR—cerebellum—migraine	0.000403	0.0325	CbGeAlD
Temsirolimus—MTOR—FSH signaling pathway—BDNF—migraine	0.000388	0.0257	CbGpPWpGaD
Temsirolimus—FKBP1A—nervous system—migraine	0.000385	0.031	CbGeAlD
Temsirolimus—FKBP1A—central nervous system—migraine	0.000371	0.0299	CbGeAlD
Temsirolimus—MTOR—Extracellular vesicle-mediated signaling in recipient cells—TGFBR2—migraine	0.00037	0.0245	CbGpPWpGaD
Temsirolimus—FKBP1A—cerebellum—migraine	0.000363	0.0292	CbGeAlD
Temsirolimus—Connective tissue disorder—Timolol—migraine	0.000355	0.00159	CcSEcCtD
Temsirolimus—Dysphagia—Topiramate—migraine	0.000353	0.00159	CcSEcCtD
Temsirolimus—Epistaxis—Gabapentin—migraine	0.000353	0.00159	CcSEcCtD
Temsirolimus—Malnutrition—Valproic Acid—migraine	0.000353	0.00158	CcSEcCtD
Temsirolimus—Sinusitis—Gabapentin—migraine	0.000351	0.00158	CcSEcCtD
Temsirolimus—Fatigue—Verapamil—migraine	0.00035	0.00157	CcSEcCtD
Temsirolimus—Abdominal pain—Propranolol—migraine	0.000349	0.00157	CcSEcCtD
Temsirolimus—Body temperature increased—Propranolol—migraine	0.000349	0.00157	CcSEcCtD
Temsirolimus—Pain—Verapamil—migraine	0.000348	0.00156	CcSEcCtD
Temsirolimus—Constipation—Verapamil—migraine	0.000348	0.00156	CcSEcCtD
Temsirolimus—Dysgeusia—Valproic Acid—migraine	0.000346	0.00155	CcSEcCtD
Temsirolimus—Vomiting—Amitriptyline—migraine	0.000345	0.00155	CcSEcCtD
Temsirolimus—Rash—Amitriptyline—migraine	0.000342	0.00154	CcSEcCtD
Temsirolimus—Dermatitis—Amitriptyline—migraine	0.000342	0.00153	CcSEcCtD
Temsirolimus—Back pain—Valproic Acid—migraine	0.000342	0.00153	CcSEcCtD
Temsirolimus—Headache—Amitriptyline—migraine	0.00034	0.00153	CcSEcCtD
Temsirolimus—Bronchitis—Topiramate—migraine	0.00034	0.00153	CcSEcCtD
Temsirolimus—Eye disorder—Timolol—migraine	0.000337	0.00151	CcSEcCtD
Temsirolimus—Rhinitis—Gabapentin—migraine	0.000337	0.00151	CcSEcCtD
Temsirolimus—Cardiac disorder—Timolol—migraine	0.000335	0.0015	CcSEcCtD
Temsirolimus—FKBP1A—Loss of Function of SMAD2/3 in Cancer—TGFBR2—migraine	0.000334	0.0222	CbGpPWpGaD
Temsirolimus—Pharyngitis—Gabapentin—migraine	0.000334	0.0015	CcSEcCtD
Temsirolimus—Urinary tract disorder—Gabapentin—migraine	0.000332	0.00149	CcSEcCtD
Temsirolimus—Oedema peripheral—Gabapentin—migraine	0.000331	0.00149	CcSEcCtD
Temsirolimus—Neutropenia—Topiramate—migraine	0.00033	0.00148	CcSEcCtD
Temsirolimus—Dysuria—Topiramate—migraine	0.00033	0.00148	CcSEcCtD
Temsirolimus—Connective tissue disorder—Gabapentin—migraine	0.00033	0.00148	CcSEcCtD
Temsirolimus—Urethral disorder—Gabapentin—migraine	0.00033	0.00148	CcSEcCtD
Temsirolimus—Upper respiratory tract infection—Topiramate—migraine	0.000328	0.00147	CcSEcCtD
Temsirolimus—Angiopathy—Timolol—migraine	0.000328	0.00147	CcSEcCtD
Temsirolimus—MTOR—brain—migraine	0.000328	0.0264	CbGeAlD
Temsirolimus—Pollakiuria—Topiramate—migraine	0.000326	0.00147	CcSEcCtD
Temsirolimus—Anaemia—Valproic Acid—migraine	0.000326	0.00146	CcSEcCtD
Temsirolimus—Immune system disorder—Timolol—migraine	0.000326	0.00146	CcSEcCtD
Temsirolimus—Hypersensitivity—Propranolol—migraine	0.000326	0.00146	CcSEcCtD
Temsirolimus—Mediastinal disorder—Timolol—migraine	0.000325	0.00146	CcSEcCtD
Temsirolimus—Angioedema—Valproic Acid—migraine	0.000323	0.00145	CcSEcCtD
Temsirolimus—Nausea—Amitriptyline—migraine	0.000322	0.00145	CcSEcCtD
Temsirolimus—Weight decreased—Topiramate—migraine	0.00032	0.00144	CcSEcCtD
Temsirolimus—Hyperglycaemia—Topiramate—migraine	0.000319	0.00143	CcSEcCtD
Temsirolimus—Erythema multiforme—Gabapentin—migraine	0.000318	0.00143	CcSEcCtD
Temsirolimus—Asthenia—Propranolol—migraine	0.000317	0.00142	CcSEcCtD
Temsirolimus—Pneumonia—Topiramate—migraine	0.000317	0.00142	CcSEcCtD
Temsirolimus—Mental disorder—Timolol—migraine	0.000316	0.00142	CcSEcCtD
Temsirolimus—Leukopenia—Valproic Acid—migraine	0.000316	0.00142	CcSEcCtD
Temsirolimus—Infestation—Topiramate—migraine	0.000315	0.00141	CcSEcCtD
Temsirolimus—Infestation NOS—Topiramate—migraine	0.000315	0.00141	CcSEcCtD
Temsirolimus—Malnutrition—Timolol—migraine	0.000314	0.00141	CcSEcCtD
Temsirolimus—Erythema—Timolol—migraine	0.000314	0.00141	CcSEcCtD
Temsirolimus—Eye disorder—Gabapentin—migraine	0.000314	0.00141	CcSEcCtD
Temsirolimus—Depression—Topiramate—migraine	0.000314	0.00141	CcSEcCtD
Temsirolimus—Stevens-Johnson syndrome—Topiramate—migraine	0.000312	0.0014	CcSEcCtD
Temsirolimus—Cardiac disorder—Gabapentin—migraine	0.000312	0.0014	CcSEcCtD
Temsirolimus—ABCB1—blood vessel—migraine	0.000311	0.0251	CbGeAlD
Temsirolimus—Renal failure—Topiramate—migraine	0.00031	0.00139	CcSEcCtD
Temsirolimus—Cough—Valproic Acid—migraine	0.000308	0.00138	CcSEcCtD
Temsirolimus—Dysgeusia—Timolol—migraine	0.000308	0.00138	CcSEcCtD
Temsirolimus—Stomatitis—Topiramate—migraine	0.000307	0.00138	CcSEcCtD
Temsirolimus—Conjunctivitis—Topiramate—migraine	0.000306	0.00137	CcSEcCtD
Temsirolimus—Urinary tract infection—Topiramate—migraine	0.000306	0.00137	CcSEcCtD
Temsirolimus—Hypertension—Valproic Acid—migraine	0.000305	0.00137	CcSEcCtD
Temsirolimus—Immune system disorder—Gabapentin—migraine	0.000304	0.00136	CcSEcCtD
Temsirolimus—Mediastinal disorder—Gabapentin—migraine	0.000303	0.00136	CcSEcCtD
Temsirolimus—Diarrhoea—Propranolol—migraine	0.000302	0.00136	CcSEcCtD
Temsirolimus—Chills—Gabapentin—migraine	0.000302	0.00135	CcSEcCtD
Temsirolimus—Chest pain—Valproic Acid—migraine	0.000301	0.00135	CcSEcCtD
Temsirolimus—Myalgia—Valproic Acid—migraine	0.000301	0.00135	CcSEcCtD
Temsirolimus—Arthralgia—Valproic Acid—migraine	0.000301	0.00135	CcSEcCtD
Temsirolimus—Haematuria—Topiramate—migraine	0.0003	0.00135	CcSEcCtD
Temsirolimus—Anxiety—Valproic Acid—migraine	0.0003	0.00134	CcSEcCtD
Temsirolimus—Hypersensitivity—Verapamil—migraine	0.000299	0.00134	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000299	0.00134	CcSEcCtD
Temsirolimus—Epistaxis—Topiramate—migraine	0.000297	0.00133	CcSEcCtD
Temsirolimus—Sinusitis—Topiramate—migraine	0.000296	0.00133	CcSEcCtD
Temsirolimus—FKBP1A—brain—migraine	0.000295	0.0237	CbGeAlD
Temsirolimus—Mental disorder—Gabapentin—migraine	0.000295	0.00132	CcSEcCtD
Temsirolimus—Malnutrition—Gabapentin—migraine	0.000293	0.00131	CcSEcCtD
Temsirolimus—Erythema—Gabapentin—migraine	0.000293	0.00131	CcSEcCtD
Temsirolimus—Dizziness—Propranolol—migraine	0.000292	0.00131	CcSEcCtD
Temsirolimus—Asthenia—Verapamil—migraine	0.000292	0.00131	CcSEcCtD
Temsirolimus—Anaphylactic shock—Valproic Acid—migraine	0.000288	0.00129	CcSEcCtD
Temsirolimus—Oedema—Valproic Acid—migraine	0.000288	0.00129	CcSEcCtD
Temsirolimus—Pruritus—Verapamil—migraine	0.000288	0.00129	CcSEcCtD
Temsirolimus—Angioedema—Timolol—migraine	0.000287	0.00129	CcSEcCtD
Temsirolimus—Dysgeusia—Gabapentin—migraine	0.000287	0.00129	CcSEcCtD
Temsirolimus—Infection—Valproic Acid—migraine	0.000286	0.00129	CcSEcCtD
Temsirolimus—Rhinitis—Topiramate—migraine	0.000284	0.00127	CcSEcCtD
Temsirolimus—Back pain—Gabapentin—migraine	0.000283	0.00127	CcSEcCtD
Temsirolimus—Nervous system disorder—Valproic Acid—migraine	0.000283	0.00127	CcSEcCtD
Temsirolimus—Thrombocytopenia—Valproic Acid—migraine	0.000282	0.00127	CcSEcCtD
Temsirolimus—Vomiting—Propranolol—migraine	0.000281	0.00126	CcSEcCtD
Temsirolimus—Pharyngitis—Topiramate—migraine	0.000281	0.00126	CcSEcCtD
Temsirolimus—Skin disorder—Valproic Acid—migraine	0.00028	0.00126	CcSEcCtD
Temsirolimus—Urinary tract disorder—Topiramate—migraine	0.000279	0.00125	CcSEcCtD
Temsirolimus—Oedema peripheral—Topiramate—migraine	0.000279	0.00125	CcSEcCtD
Temsirolimus—Rash—Propranolol—migraine	0.000279	0.00125	CcSEcCtD
Temsirolimus—Dermatitis—Propranolol—migraine	0.000278	0.00125	CcSEcCtD
Temsirolimus—Diarrhoea—Verapamil—migraine	0.000278	0.00125	CcSEcCtD
Temsirolimus—Connective tissue disorder—Topiramate—migraine	0.000278	0.00125	CcSEcCtD
Temsirolimus—Urethral disorder—Topiramate—migraine	0.000277	0.00124	CcSEcCtD
Temsirolimus—Anorexia—Valproic Acid—migraine	0.000275	0.00123	CcSEcCtD
Temsirolimus—Cough—Timolol—migraine	0.000274	0.00123	CcSEcCtD
Temsirolimus—Hypertension—Timolol—migraine	0.000271	0.00122	CcSEcCtD
Temsirolimus—Anaemia—Gabapentin—migraine	0.000271	0.00121	CcSEcCtD
Temsirolimus—Dizziness—Verapamil—migraine	0.000269	0.00121	CcSEcCtD
Temsirolimus—Myalgia—Timolol—migraine	0.000268	0.0012	CcSEcCtD
Temsirolimus—Arthralgia—Timolol—migraine	0.000268	0.0012	CcSEcCtD
Temsirolimus—Chest pain—Timolol—migraine	0.000268	0.0012	CcSEcCtD
Temsirolimus—FKBP1A—TGF-beta Receptor Signaling—FOS—migraine	0.000268	0.0177	CbGpPWpGaD
Temsirolimus—Erythema multiforme—Topiramate—migraine	0.000267	0.0012	CcSEcCtD
Temsirolimus—Angioedema—Gabapentin—migraine	0.000267	0.0012	CcSEcCtD
Temsirolimus—Anxiety—Timolol—migraine	0.000267	0.0012	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000266	0.00119	CcSEcCtD
Temsirolimus—Eye disorder—Topiramate—migraine	0.000264	0.00119	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Valproic Acid—migraine	0.000263	0.00118	CcSEcCtD
Temsirolimus—Cardiac disorder—Topiramate—migraine	0.000263	0.00118	CcSEcCtD
Temsirolimus—Nausea—Propranolol—migraine	0.000262	0.00118	CcSEcCtD
Temsirolimus—Leukopenia—Gabapentin—migraine	0.000262	0.00118	CcSEcCtD
Temsirolimus—Insomnia—Valproic Acid—migraine	0.000261	0.00117	CcSEcCtD
Temsirolimus—Vomiting—Verapamil—migraine	0.000258	0.00116	CcSEcCtD
Temsirolimus—Dyspnoea—Valproic Acid—migraine	0.000257	0.00115	CcSEcCtD
Temsirolimus—Angiopathy—Topiramate—migraine	0.000257	0.00115	CcSEcCtD
Temsirolimus—Anaphylactic shock—Timolol—migraine	0.000257	0.00115	CcSEcCtD
Temsirolimus—Oedema—Timolol—migraine	0.000257	0.00115	CcSEcCtD
Temsirolimus—Rash—Verapamil—migraine	0.000256	0.00115	CcSEcCtD
Temsirolimus—Somnolence—Valproic Acid—migraine	0.000256	0.00115	CcSEcCtD
Temsirolimus—Dermatitis—Verapamil—migraine	0.000256	0.00115	CcSEcCtD
Temsirolimus—Immune system disorder—Topiramate—migraine	0.000256	0.00115	CcSEcCtD
Temsirolimus—Cough—Gabapentin—migraine	0.000255	0.00115	CcSEcCtD
Temsirolimus—Mediastinal disorder—Topiramate—migraine	0.000255	0.00114	CcSEcCtD
Temsirolimus—Infection—Timolol—migraine	0.000255	0.00114	CcSEcCtD
Temsirolimus—Headache—Verapamil—migraine	0.000255	0.00114	CcSEcCtD
Temsirolimus—Chills—Topiramate—migraine	0.000254	0.00114	CcSEcCtD
Temsirolimus—MTOR—EGF/EGFR Signaling Pathway—MEF2D—migraine	0.000254	0.0168	CbGpPWpGaD
Temsirolimus—Convulsion—Gabapentin—migraine	0.000254	0.00114	CcSEcCtD
Temsirolimus—Hypertension—Gabapentin—migraine	0.000253	0.00113	CcSEcCtD
Temsirolimus—Nervous system disorder—Timolol—migraine	0.000252	0.00113	CcSEcCtD
Temsirolimus—Decreased appetite—Valproic Acid—migraine	0.00025	0.00112	CcSEcCtD
Temsirolimus—Myalgia—Gabapentin—migraine	0.000249	0.00112	CcSEcCtD
Temsirolimus—Arthralgia—Gabapentin—migraine	0.000249	0.00112	CcSEcCtD
Temsirolimus—Chest pain—Gabapentin—migraine	0.000249	0.00112	CcSEcCtD
Temsirolimus—Skin disorder—Timolol—migraine	0.000249	0.00112	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Valproic Acid—migraine	0.000249	0.00112	CcSEcCtD
Temsirolimus—Fatigue—Valproic Acid—migraine	0.000248	0.00112	CcSEcCtD
Temsirolimus—Anxiety—Gabapentin—migraine	0.000248	0.00111	CcSEcCtD
Temsirolimus—Mental disorder—Topiramate—migraine	0.000248	0.00111	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000247	0.00111	CcSEcCtD
Temsirolimus—Pain—Valproic Acid—migraine	0.000246	0.00111	CcSEcCtD
Temsirolimus—Constipation—Valproic Acid—migraine	0.000246	0.00111	CcSEcCtD
Temsirolimus—Erythema—Topiramate—migraine	0.000246	0.00111	CcSEcCtD
Temsirolimus—Malnutrition—Topiramate—migraine	0.000246	0.00111	CcSEcCtD
Temsirolimus—Anorexia—Timolol—migraine	0.000245	0.0011	CcSEcCtD
Temsirolimus—Nausea—Verapamil—migraine	0.000241	0.00108	CcSEcCtD
Temsirolimus—Dysgeusia—Topiramate—migraine	0.000241	0.00108	CcSEcCtD
Temsirolimus—Anaphylactic shock—Gabapentin—migraine	0.000239	0.00107	CcSEcCtD
Temsirolimus—Oedema—Gabapentin—migraine	0.000239	0.00107	CcSEcCtD
Temsirolimus—Back pain—Topiramate—migraine	0.000238	0.00107	CcSEcCtD
Temsirolimus—Infection—Gabapentin—migraine	0.000237	0.00107	CcSEcCtD
Temsirolimus—CYP2D6—brainstem—migraine	0.000237	0.019	CbGeAlD
Temsirolimus—Gastrointestinal pain—Valproic Acid—migraine	0.000236	0.00106	CcSEcCtD
Temsirolimus—Nervous system disorder—Gabapentin—migraine	0.000234	0.00105	CcSEcCtD
Temsirolimus—Thrombocytopenia—Gabapentin—migraine	0.000234	0.00105	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Timolol—migraine	0.000234	0.00105	CcSEcCtD
Temsirolimus—Skin disorder—Gabapentin—migraine	0.000232	0.00104	CcSEcCtD
Temsirolimus—Insomnia—Timolol—migraine	0.000232	0.00104	CcSEcCtD
Temsirolimus—Dyspnoea—Timolol—migraine	0.000229	0.00103	CcSEcCtD
Temsirolimus—Somnolence—Timolol—migraine	0.000228	0.00102	CcSEcCtD
Temsirolimus—Abdominal pain—Valproic Acid—migraine	0.000228	0.00102	CcSEcCtD
Temsirolimus—Body temperature increased—Valproic Acid—migraine	0.000228	0.00102	CcSEcCtD
Temsirolimus—Anorexia—Gabapentin—migraine	0.000228	0.00102	CcSEcCtD
Temsirolimus—Anaemia—Topiramate—migraine	0.000228	0.00102	CcSEcCtD
Temsirolimus—Decreased appetite—Timolol—migraine	0.000223	0.001	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Timolol—migraine	0.000221	0.000994	CcSEcCtD
Temsirolimus—Fatigue—Timolol—migraine	0.000221	0.000993	CcSEcCtD
Temsirolimus—Leukopenia—Topiramate—migraine	0.00022	0.000989	CcSEcCtD
Temsirolimus—Pain—Timolol—migraine	0.000219	0.000985	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Gabapentin—migraine	0.000218	0.000977	CcSEcCtD
Temsirolimus—Insomnia—Gabapentin—migraine	0.000216	0.00097	CcSEcCtD
Temsirolimus—Cough—Topiramate—migraine	0.000215	0.000965	CcSEcCtD
Temsirolimus—Convulsion—Topiramate—migraine	0.000213	0.000958	CcSEcCtD
Temsirolimus—Dyspnoea—Gabapentin—migraine	0.000213	0.000956	CcSEcCtD
Temsirolimus—Hypertension—Topiramate—migraine	0.000213	0.000954	CcSEcCtD
Temsirolimus—Somnolence—Gabapentin—migraine	0.000212	0.000953	CcSEcCtD
Temsirolimus—Hypersensitivity—Valproic Acid—migraine	0.000212	0.000953	CcSEcCtD
Temsirolimus—FKBP1A—Spinal Cord Injury—BDNF—migraine	0.000212	0.014	CbGpPWpGaD
Temsirolimus—Gastrointestinal pain—Timolol—migraine	0.00021	0.000942	CcSEcCtD
Temsirolimus—Arthralgia—Topiramate—migraine	0.00021	0.000941	CcSEcCtD
Temsirolimus—Chest pain—Topiramate—migraine	0.00021	0.000941	CcSEcCtD
Temsirolimus—Myalgia—Topiramate—migraine	0.00021	0.000941	CcSEcCtD
Temsirolimus—Anxiety—Topiramate—migraine	0.000209	0.000938	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000208	0.000935	CcSEcCtD
Temsirolimus—Decreased appetite—Gabapentin—migraine	0.000208	0.000932	CcSEcCtD
Temsirolimus—Asthenia—Valproic Acid—migraine	0.000207	0.000928	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Gabapentin—migraine	0.000206	0.000926	CcSEcCtD
Temsirolimus—Fatigue—Gabapentin—migraine	0.000206	0.000924	CcSEcCtD
Temsirolimus—Pain—Gabapentin—migraine	0.000204	0.000917	CcSEcCtD
Temsirolimus—Constipation—Gabapentin—migraine	0.000204	0.000917	CcSEcCtD
Temsirolimus—Pruritus—Valproic Acid—migraine	0.000204	0.000915	CcSEcCtD
Temsirolimus—Abdominal pain—Timolol—migraine	0.000203	0.00091	CcSEcCtD
Temsirolimus—Body temperature increased—Timolol—migraine	0.000203	0.00091	CcSEcCtD
Temsirolimus—Oedema—Topiramate—migraine	0.000201	0.000902	CcSEcCtD
Temsirolimus—MTOR—LKB1 signaling events—ESR1—migraine	0.0002	0.0133	CbGpPWpGaD
Temsirolimus—Infection—Topiramate—migraine	0.0002	0.000896	CcSEcCtD
Temsirolimus—Diarrhoea—Valproic Acid—migraine	0.000197	0.000885	CcSEcCtD
Temsirolimus—Nervous system disorder—Topiramate—migraine	0.000197	0.000885	CcSEcCtD
Temsirolimus—Thrombocytopenia—Topiramate—migraine	0.000197	0.000883	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Gabapentin—migraine	0.000195	0.000877	CcSEcCtD
Temsirolimus—Skin disorder—Topiramate—migraine	0.000195	0.000876	CcSEcCtD
Temsirolimus—ABCB1—trigeminal ganglion—migraine	0.000192	0.0155	CbGeAlD
Temsirolimus—Anorexia—Topiramate—migraine	0.000192	0.00086	CcSEcCtD
Temsirolimus—Dizziness—Valproic Acid—migraine	0.000191	0.000855	CcSEcCtD
Temsirolimus—Hypersensitivity—Timolol—migraine	0.000189	0.000848	CcSEcCtD
Temsirolimus—Body temperature increased—Gabapentin—migraine	0.000189	0.000848	CcSEcCtD
Temsirolimus—Abdominal pain—Gabapentin—migraine	0.000189	0.000848	CcSEcCtD
Temsirolimus—MTOR—ErbB2/ErbB3 signaling events—FOS—migraine	0.000188	0.0124	CbGpPWpGaD
Temsirolimus—Asthenia—Timolol—migraine	0.000184	0.000826	CcSEcCtD
Temsirolimus—Vomiting—Valproic Acid—migraine	0.000183	0.000822	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Topiramate—migraine	0.000183	0.000822	CcSEcCtD
Temsirolimus—Insomnia—Topiramate—migraine	0.000182	0.000816	CcSEcCtD
Temsirolimus—Rash—Valproic Acid—migraine	0.000182	0.000816	CcSEcCtD
Temsirolimus—Dermatitis—Valproic Acid—migraine	0.000182	0.000815	CcSEcCtD
Temsirolimus—Pruritus—Timolol—migraine	0.000181	0.000815	CcSEcCtD
Temsirolimus—Headache—Valproic Acid—migraine	0.000181	0.00081	CcSEcCtD
Temsirolimus—Dyspnoea—Topiramate—migraine	0.000179	0.000804	CcSEcCtD
Temsirolimus—Somnolence—Topiramate—migraine	0.000179	0.000802	CcSEcCtD
Temsirolimus—Hypersensitivity—Gabapentin—migraine	0.000176	0.00079	CcSEcCtD
Temsirolimus—Diarrhoea—Timolol—migraine	0.000176	0.000788	CcSEcCtD
Temsirolimus—Decreased appetite—Topiramate—migraine	0.000175	0.000784	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Topiramate—migraine	0.000174	0.000779	CcSEcCtD
Temsirolimus—Fatigue—Topiramate—migraine	0.000173	0.000778	CcSEcCtD
Temsirolimus—Constipation—Topiramate—migraine	0.000172	0.000771	CcSEcCtD
Temsirolimus—Pain—Topiramate—migraine	0.000172	0.000771	CcSEcCtD
Temsirolimus—Asthenia—Gabapentin—migraine	0.000171	0.000769	CcSEcCtD
Temsirolimus—Nausea—Valproic Acid—migraine	0.000171	0.000768	CcSEcCtD
Temsirolimus—Dizziness—Timolol—migraine	0.00017	0.000761	CcSEcCtD
Temsirolimus—Pruritus—Gabapentin—migraine	0.000169	0.000759	CcSEcCtD
Temsirolimus—MTOR—Type II diabetes mellitus—TNF—migraine	0.000166	0.011	CbGpPWpGaD
Temsirolimus—Gastrointestinal pain—Topiramate—migraine	0.000164	0.000738	CcSEcCtD
Temsirolimus—Diarrhoea—Gabapentin—migraine	0.000163	0.000734	CcSEcCtD
Temsirolimus—Vomiting—Timolol—migraine	0.000163	0.000732	CcSEcCtD
Temsirolimus—Rash—Timolol—migraine	0.000162	0.000726	CcSEcCtD
Temsirolimus—Dermatitis—Timolol—migraine	0.000162	0.000725	CcSEcCtD
Temsirolimus—Headache—Timolol—migraine	0.000161	0.000721	CcSEcCtD
Temsirolimus—Abdominal pain—Topiramate—migraine	0.000159	0.000713	CcSEcCtD
Temsirolimus—Body temperature increased—Topiramate—migraine	0.000159	0.000713	CcSEcCtD
Temsirolimus—Dizziness—Gabapentin—migraine	0.000158	0.000709	CcSEcCtD
Temsirolimus—Nausea—Timolol—migraine	0.000152	0.000684	CcSEcCtD
Temsirolimus—Vomiting—Gabapentin—migraine	0.000152	0.000682	CcSEcCtD
Temsirolimus—Rash—Gabapentin—migraine	0.000151	0.000676	CcSEcCtD
Temsirolimus—Dermatitis—Gabapentin—migraine	0.00015	0.000675	CcSEcCtD
Temsirolimus—Headache—Gabapentin—migraine	0.00015	0.000672	CcSEcCtD
Temsirolimus—MTOR—RANKL/RANK Signaling Pathway—FOS—migraine	0.000148	0.00983	CbGpPWpGaD
Temsirolimus—Hypersensitivity—Topiramate—migraine	0.000148	0.000665	CcSEcCtD
Temsirolimus—Asthenia—Topiramate—migraine	0.000144	0.000647	CcSEcCtD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—BDNF—migraine	0.000144	0.00955	CbGpPWpGaD
Temsirolimus—FKBP1A—TGF-beta Receptor Signaling—TNF—migraine	0.000144	0.00954	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—FOS—migraine	0.000143	0.00949	CbGpPWpGaD
Temsirolimus—Pruritus—Topiramate—migraine	0.000142	0.000638	CcSEcCtD
Temsirolimus—Nausea—Gabapentin—migraine	0.000142	0.000637	CcSEcCtD
Temsirolimus—ABCB1—cardiovascular system—migraine	0.000139	0.0112	CbGeAlD
Temsirolimus—MTOR—Regulation of Telomerase—ESR1—migraine	0.000139	0.0092	CbGpPWpGaD
Temsirolimus—MTOR—IL12-mediated signaling events—FOS—migraine	0.000138	0.00917	CbGpPWpGaD
Temsirolimus—Diarrhoea—Topiramate—migraine	0.000138	0.000617	CcSEcCtD
Temsirolimus—MTOR—Signaling by ERBB4—PGR—migraine	0.000137	0.00906	CbGpPWpGaD
Temsirolimus—Dizziness—Topiramate—migraine	0.000133	0.000597	CcSEcCtD
Temsirolimus—CYP2D6—head—migraine	0.000131	0.0105	CbGeAlD
Temsirolimus—MTOR—Oncostatin M Signaling Pathway—FOS—migraine	0.00013	0.0086	CbGpPWpGaD
Temsirolimus—MTOR—Leptin signaling pathway—ESR1—migraine	0.000128	0.00851	CbGpPWpGaD
Temsirolimus—MTOR—TSH signaling pathway—FOS—migraine	0.000128	0.0085	CbGpPWpGaD
Temsirolimus—Vomiting—Topiramate—migraine	0.000128	0.000574	CcSEcCtD
Temsirolimus—Rash—Topiramate—migraine	0.000127	0.000569	CcSEcCtD
Temsirolimus—Dermatitis—Topiramate—migraine	0.000127	0.000568	CcSEcCtD
Temsirolimus—CYP3A4—nervous system—migraine	0.000126	0.0101	CbGeAlD
Temsirolimus—Headache—Topiramate—migraine	0.000126	0.000565	CcSEcCtD
Temsirolimus—MTOR—Regulation of Telomerase—FOS—migraine	0.000125	0.0083	CbGpPWpGaD
Temsirolimus—CYP2D6—nervous system—migraine	0.000124	0.00998	CbGeAlD
Temsirolimus—CYP3A4—central nervous system—migraine	0.000121	0.00976	CbGeAlD
Temsirolimus—Nausea—Topiramate—migraine	0.000119	0.000536	CcSEcCtD
Temsirolimus—CYP2D6—central nervous system—migraine	0.000119	0.00961	CbGeAlD
Temsirolimus—CYP2D6—cerebellum—migraine	0.000117	0.00939	CbGeAlD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—ESR1—migraine	0.000108	0.00716	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—TGFBR2—migraine	0.000102	0.00674	CbGpPWpGaD
Temsirolimus—MTOR—BDNF signaling pathway—BDNF—migraine	0.000102	0.00673	CbGpPWpGaD
Temsirolimus—CYP2D6—brain—migraine	9.47e-05	0.00763	CbGeAlD
Temsirolimus—ABCB1—head—migraine	9.4e-05	0.00757	CbGeAlD
Temsirolimus—ABCB1—nervous system—migraine	8.92e-05	0.00718	CbGeAlD
Temsirolimus—MTOR—ErbB1 downstream signaling—FOS—migraine	8.84e-05	0.00586	CbGpPWpGaD
Temsirolimus—ABCB1—central nervous system—migraine	8.58e-05	0.00691	CbGeAlD
Temsirolimus—ABCB1—cerebellum—migraine	8.39e-05	0.00675	CbGeAlD
Temsirolimus—MTOR—Cardiac Hypertrophic Response—TNF—migraine	7.97e-05	0.00528	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—TNF—migraine	7.7e-05	0.0051	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CALCRL—migraine	7.54e-05	0.005	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—RAMP1—migraine	7.54e-05	0.005	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—ESR1—migraine	7.33e-05	0.00486	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—ESR1—migraine	7.29e-05	0.00484	CbGpPWpGaD
Temsirolimus—MTOR—BDNF signaling pathway—FOS—migraine	6.86e-05	0.00455	CbGpPWpGaD
Temsirolimus—ABCB1—brain—migraine	6.81e-05	0.00549	CbGeAlD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—TRPM8—migraine	6.45e-05	0.00427	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—LRP1—migraine	6.4e-05	0.00425	CbGpPWpGaD
Temsirolimus—MTOR—Insulin Signaling—FOS—migraine	6.31e-05	0.00418	CbGpPWpGaD
Temsirolimus—MTOR—EGF/EGFR Signaling Pathway—FOS—migraine	6.25e-05	0.00414	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—FOS—migraine	5.82e-05	0.00386	CbGpPWpGaD
Temsirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TNF—migraine	5.68e-05	0.00377	CbGpPWpGaD
Temsirolimus—ABCB1—HIF-1-alpha transcription factor network—FOS—migraine	5.52e-05	0.00366	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—HTR1D—migraine	5.48e-05	0.00363	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TNF—migraine	5.23e-05	0.00347	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—HTR2B—migraine	5.09e-05	0.00338	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—ATP1A3—migraine	4.89e-05	0.00324	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—ATP1A2—migraine	4.89e-05	0.00324	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—LRP1—migraine	4.48e-05	0.00297	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CALCRL—migraine	4.24e-05	0.00281	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—RAMP1—migraine	4.24e-05	0.00281	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—FOS—migraine	4.23e-05	0.0028	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—HTR3A—migraine	4.15e-05	0.00275	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CALCA—migraine	4.13e-05	0.00274	CbGpPWpGaD
Temsirolimus—MTOR—Disease—LRP1—migraine	3.6e-05	0.00239	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	3.49e-05	0.00231	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—NOTCH4—migraine	3.44e-05	0.00228	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—TGFBR2—migraine	3.32e-05	0.0022	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—HTR1B—migraine	3.32e-05	0.0022	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—HTR1A—migraine	3.19e-05	0.00212	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—NPS—migraine	3.15e-05	0.00209	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TAC1—migraine	3.15e-05	0.00209	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PGR—migraine	3.15e-05	0.00209	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—HTR2C—migraine	3.09e-05	0.00205	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HTR1D—migraine	3.08e-05	0.00204	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CACNA1A—migraine	3.03e-05	0.00201	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—EDNRA—migraine	3e-05	0.00199	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—NOTCH3—migraine	2.93e-05	0.00194	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CALCA—migraine	2.89e-05	0.00192	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HTR2B—migraine	2.86e-05	0.0019	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—HTR7—migraine	2.7e-05	0.00179	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—MTHFR—migraine	2.7e-05	0.00179	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	2.62e-05	0.00173	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—TNF—migraine	2.57e-05	0.0017	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—LRP1—migraine	2.52e-05	0.00167	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TGFBR2—migraine	2.33e-05	0.00154	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CALCA—migraine	2.32e-05	0.00154	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—FOS—migraine	2.26e-05	0.0015	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CACNA1A—migraine	2.19e-05	0.00145	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NOTCH4—migraine	1.93e-05	0.00128	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—HTR2A—migraine	1.89e-05	0.00126	CbGpPWpGaD
Temsirolimus—MTOR—Disease—TGFBR2—migraine	1.87e-05	0.00124	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HTR1B—migraine	1.87e-05	0.00124	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HTR1A—migraine	1.8e-05	0.00119	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PGR—migraine	1.77e-05	0.00117	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TAC1—migraine	1.77e-05	0.00117	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NPS—migraine	1.77e-05	0.00117	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HTR2C—migraine	1.74e-05	0.00115	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—EDNRA—migraine	1.69e-05	0.00112	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—ESR1—migraine	1.68e-05	0.00111	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CACNA1A—migraine	1.65e-05	0.0011	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NOTCH3—migraine	1.65e-05	0.00109	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CALCA—migraine	1.62e-05	0.00108	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CACNA1A—migraine	1.56e-05	0.00103	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HTR7—migraine	1.52e-05	0.00101	CbGpPWpGaD
Temsirolimus—MTOR—Disease—MTHFR—migraine	1.52e-05	0.00101	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—FOS—migraine	1.32e-05	0.000873	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TGFBR2—migraine	1.31e-05	0.000868	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	1.27e-05	0.00084	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HTR2A—migraine	1.06e-05	0.000706	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CACNA1A—migraine	1.02e-05	0.000676	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—MTHFR—migraine	1e-05	0.000665	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—ESR1—migraine	9.45e-06	0.000627	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—MTHFR—migraine	7.25e-06	0.000481	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—MTHFR—migraine	5.47e-06	0.000363	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—MTHFR—migraine	5.16e-06	0.000342	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—MTHFR—migraine	3.37e-06	0.000224	CbGpPWpGaD
